Semi-Annual Consolidated Balance Sheet

Fuji Pharma Co.,Ltd. - Filing #7712320

Concept As at
2019-03-31
As at
2018-09-30
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
6,435,000,000 JPY
6,251,000,000 JPY
Other
1,450,000,000 JPY
453,000,000 JPY
Allowance for doubtful accounts
-6,000,000 JPY
-6,000,000 JPY
Current assets
34,753,000,000 JPY
34,927,000,000 JPY
Non-current assets
Property, plant and equipment
11,688,000,000 JPY
11,700,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
5,443,000,000 JPY
5,573,000,000 JPY
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
1,735,000,000 JPY
1,814,000,000 JPY
Land
914,000,000 JPY
915,000,000 JPY
Leased assets
Leased assets, net
2,595,000,000 JPY
2,860,000,000 JPY
Construction in progress
800,000,000 JPY
315,000,000 JPY
Other
Other, net
198,000,000 JPY
220,000,000 JPY
Intangible assets
Goodwill
1,618,000,000 JPY
1,764,000,000 JPY
Other
1,790,000,000 JPY
455,000,000 JPY
Intangible assets
3,409,000,000 JPY
2,220,000,000 JPY
Investments and other assets
9,162,000,000 JPY
4,269,000,000 JPY
Investments and other assets
Investment securities
5,803,000,000 JPY
60,000,000 JPY
Other
859,000,000 JPY
861,000,000 JPY
Non-current assets
24,259,000,000 JPY
18,189,000,000 JPY
Assets
59,013,000,000 JPY
53,117,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
5,562,000,000 JPY
6,746,000,000 JPY
Lease liabilities
538,000,000 JPY
537,000,000 JPY
Income taxes payable
671,000,000 JPY
373,000,000 JPY
Other
2,061,000,000 JPY
2,695,000,000 JPY
Current liabilities
12,383,000,000 JPY
11,546,000,000 JPY
Non-current liabilities
Long-term borrowings
5,950,000,000 JPY
2,000,000,000 JPY
Lease liabilities
2,259,000,000 JPY
2,534,000,000 JPY
Retirement benefit liability
1,245,000,000 JPY
1,210,000,000 JPY
Other
420,000,000 JPY
475,000,000 JPY
Non-current liabilities
9,875,000,000 JPY
6,220,000,000 JPY
Liabilities
22,258,000,000 JPY
17,767,000,000 JPY
Provision for bonuses
679,000,000 JPY
1,161,000,000 JPY
Provision for bonuses for directors (and other officers)
4,000,000 JPY
14,000,000 JPY
Net assets
Share capital
3,799,000,000 JPY
3,799,000,000 JPY
Shareholders' equity
Capital surplus
5,023,000,000 JPY
5,023,000,000 JPY
Retained earnings
28,411,000,000 JPY
27,119,000,000 JPY
Treasury shares
-1,486,000,000 JPY
-1,504,000,000 JPY
Shareholders' equity
35,747,000,000 JPY
34,438,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
144,000,000 JPY
9,000,000 JPY
Deferred gains or losses on hedges
JPY
23,000,000 JPY
Foreign currency translation adjustment
836,000,000 JPY
850,000,000 JPY
Remeasurements of defined benefit plans
23,000,000 JPY
27,000,000 JPY
Valuation and translation adjustments
1,004,000,000 JPY
909,000,000 JPY
Non-controlling interests
2,000,000 JPY
2,000,000 JPY
Net assets
36,754,000,000 JPY
35,350,000,000 JPY
Liabilities and net assets
59,013,000,000 JPY
53,117,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.